- Home
- TEL vs BLDEW Comparison
TEL vs BLDEW Comparison
Compare TEL & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEL
- BLDEW
- Stock Information
- Founded
- TEL 1941
- BLDEW 2014
- Country
- TEL Ireland
- BLDEW United States
- Employees
- TEL N/A
- BLDEW 281
- Industry
- TEL Industrial Machinery/Components
- BLDEW Transportation Services
- Sector
- TEL Technology
- BLDEW Consumer Discretionary
- Exchange
- TEL Nasdaq
- BLDEW Nasdaq
- Market Cap
- TEL N/A
- BLDEW N/A
- IPO Year
- TEL 2007
- BLDEW N/A
- Fundamental
- Price
- TEL $142.11
- BLDEW $0.23
- Analyst Decision
- TEL Buy
- BLDEW
- Analyst Count
- TEL 10
- BLDEW 0
- Target Price
- TEL $164.10
- BLDEW N/A
- AVG Volume (30 Days)
- TEL 1.8M
- BLDEW 51.0K
- Earning Date
- TEL 04-23-2025
- BLDEW 03-13-2025
- Dividend Yield
- TEL 2.00%
- BLDEW N/A
- EPS Growth
- TEL N/A
- BLDEW N/A
- EPS
- TEL 6.27
- BLDEW N/A
- Revenue
- TEL $15,850,000,000.00
- BLDEW $241,814,000.00
- Revenue This Year
- TEL $3.16
- BLDEW N/A
- Revenue Next Year
- TEL $7.13
- BLDEW N/A
- P/E Ratio
- TEL $22.66
- BLDEW N/A
- Revenue Growth
- TEL N/A
- BLDEW 12.04
- 52 Week Low
- TEL $137.61
- BLDEW $0.30
- 52 Week High
- TEL $159.98
- BLDEW $0.36
- Technical
- Relative Strength Index (RSI)
- TEL 39.55
- BLDEW N/A
- Support Level
- TEL $143.68
- BLDEW N/A
- Resistance Level
- TEL $151.82
- BLDEW N/A
- Average True Range (ATR)
- TEL 3.33
- BLDEW 0.00
- MACD
- TEL -0.13
- BLDEW 0.00
- Stochastic Oscillator
- TEL 9.51
- BLDEW 0.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.